Navigation Links
Grand FDA nod and approval for drug for heart transplant patients

In a relief FDA, the U.S. health regulators, gave their nod to the first new drug in nearly a decade to prevent organ rejection in heart transplant patients.//

The drug, Astellas Pharma Inc.'s Prograf, is already cleared to prevent rejection of liver and kidney transplants.

Dr. Steven Galson, head of the FDA's Center for Drug Evaluation and Research said, "The doctors who perform approximately 2,200 heart transplants in the U.S. each year will now have a new option for enhancing successful outcomes. Prograf works by suppressing the body's immune system, which can attack new organs it senses as foreign objects.”

In one study of U.S. patients, 93.5 percent of patients and their new hearts survived one year after transplant. That rate was similar to what was seen in patients given an older drug, cyclosporine.

Prograf's main chemical ingredient, tacrolimus, is also used in the Japanese company's eczema cream Protopic. so now the drug can have a wider application area and used effectively.


'"/>




Page: 1

Related medicine news :

1. Taking Care Of Grandkids Can Give Women more than a Headache
2. Grandmother’s diet in pregnancy can affect grandchildren’s blood sugr
3. British Grandmother has timely bypass surgery in India
4. Grandma Recovers Eyesight Miraculously
5. Analysis Shows Lamictal As An Effective Additional Therapy For Treatment of Grand Mal Seizures
6. Ranbaxy gets US FDA approval for Lisinopril
7. Aurobindo gets U.S. FDA approval for Cephalexin
8. Cadila gets US FDA approval for Promethazine tablets
9. Anti-obesity drugs for FDA approval
10. OTC sale for Xenical; Diet Drug; gets FDA approval
11. Starvation in pregnant women can cause heart disease to their children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2016)... ... 2016 , ... Research has shown that building shame resilience ... and level of relapse. , At the 2016 iaedp Symposium, the ... the critical tasks of the recovery phase and beyond including relapse prevention and ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the ... a variety of colors, assortments and packaging. This staple for Valentine’s Day is a ... location. , For Valentine’s Day, not only are long-stem roses available, but also ...
(Date:2/5/2016)... City, UT (PRWEB) , ... February 05, 2016 , ... ... Whole-Food Nutrition , announced that the much-anticipated feature with author Jahnavi Foster, specialist in ... Humans Amateur TV Network. , Each week, on his weekly Whole-Food Warrior TV show, ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... Santa Rosa, CA (PRWEB) , ... February 05, ... ... are pleased to announce the addition of micro-needling services in their Napa Valley ... appearance. The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... -- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider of ... announced results for its fiscal year and fourth quarter ... --> GAAP results: Revenue for the fourth quarter ... 4.1% from the third quarter of 2015, and up ... 2014. Revenue for the year ended December 31, 2015 was ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: